Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Turn Therapeutics Inc. - Common Stock
(NQ:
TTRX
)
4.020
-0.230 (-5.41%)
Streaming Delayed Price
Updated: 4:00 PM EST, Nov 7, 2025
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Press Releases about Turn Therapeutics Inc. - Common Stock
Turn Therapeutics Appoints Veteran Capital Markets Executive Andrew Scott as Vice President of Corporate Communications
November 04, 2025
From
Turn Therapeutics
Via
GlobeNewswire
Turn Therapeutics Enters Global Supply, Development, and License Agreement with Leading Medical-Surgical Product Manufacturer and Distributor Medline
October 30, 2025
Agreement combines Turn’s PermaFusion® delivery platform with Medline’s global scale and distribution capabilities to advance professional and retail product opportunities
From
Turn Therapeutics
Via
GlobeNewswire
Turn Therapeutics Provides Shareholder Update Highlighting Continued Execution Across Clinical and Strategic Milestones
October 22, 2025
Company to host shareholder webinar today, October 22, 2025, at 2:00 PM ET to review execution milestones, pipeline progress, and capital strategy
From
Turn Therapeutics
Via
GlobeNewswire
Turn Therapeutics Launches Webinar Series for Ongoing Shareholder Engagement, First Session October 22, 2025
October 20, 2025
From
Turn Therapeutics
Via
GlobeNewswire
Turn Therapeutics Appoints Dr. Kent Kester to Board of Directors
October 15, 2025
Seasoned clinician and R&D leader brings extensive experience in translational medicine, drug development, and infectious disease research
From
Turn Therapeutics
Via
GlobeNewswire
Turn Therapeutics Appoints Arthur Golden to Board of Directors
October 14, 2025
Veteran corporate advisor to strengthen governance, oversight, and strategic execution as the Company advances late-stage programs
From
Turn Therapeutics
Via
GlobeNewswire
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.